Bone & Joint Hospital is a licensed 102 -- bed, orthopedic
specialty hospital providing surgical, medical and comprehensive
medical rehabilitative care. The medical staff includes specialists
in orthopedic surgery, pediatric orthopedic surgery,
anesthesiology/pain management, musculoskeletal radiology, spine
surgery, sports medicine and orthopedic trauma.
Currently, a variety of studies are being conducted which
involve either joint implant devices or pharmaceuticals. We strive
to offer our patients the best of new technology as well as
attention to their individual needs.
Bone & Joint Hospital is accredited by The Joint Commission
and is a member of the American and Oklahoma Hospital
Associations.
Several physicians have participated in component and
pharmaceutical trials in past years. In the late 1996, Helen
Kelley, RN, Ph.D., CCRP was hired to focus on developing research
capabilities and to recruit studies of potential benefit to our
patient population. We have completed studies in Phases I, II, III,
and IV. Our Research Department staff includes 4 full time study
coordinators: Daniel Dodson, Ph.D., ATC; Reda Mewhorter, MLT
(ASCP), CCRP; Lori Patton, MT (ASCP) CCRP; and Delana Rodgers,
LPN.
Bone & Joint Hospital or its affiliates has other
capabilities which include radiology, laboratory, MRI, and DEXA
bone density equipment. We are located across the street from St.
Anthony Hospital, which has additional full service availability of
CT, bone scanning, ultrasound, and venography. Many of our
physicians serve as clinical faculty at the nearby University of
Oklahoma Health Sciences Center, or in the Osteopathic Medicine
Department of Oklahoma State University.
Our physicians have a variety of interests. The interests of our
orthopedists include upper and lower extremity joint replacement
(primary and revision), sports medicine, spine surgery, and
arthroscopy. In Rheumatology, our physicians have particular
interest in osteoarthritis, rheumatoid arthritis, chronic pain,
systemic lupus, and osteoporosis. We have worked with a number of
companies, including Sulzer (Centerpulse) Orthopedics, Encore
Orthopedics, SmithKline Beecham, Ortho Biotech, Searle, Merck,
Bristol Myers Squibb, Centocor, Aventis, Amgen, Novartis, XOMA,
Abbott, Eli Lilly, Genentech, Human Genome Sciences, Alza, Valex
Pharmaceuticals, Targeted Genetics Corporation, Hoffman- LaRoche,
CombinatoRx, and UCB.
R. Eugene Arthur, MD
Internal Medicine/Rheumatology. Principal
Investigator:Studies of biologic intravenous pharmaceuticals
for RA and SLE. Studies of NSAID pharmaceuticals in OA patients;
Studies of anti – TNF pharmaceuticals in RA; Pharmaceutical
treatment of hypertension.
Subinvestigator: Study of NSAID pharmaceuticals in RA
patients; Study of TNF inhibitor for RA; Study of NSAID
pharmaceuticals in OA patients; compliance study of osteoporosis
patients.
Robert F. Hynd, MD
Internal Medicine/Rheumatology. Principal Investigator:
Studies of NSAID pharmaceuticals in OA patients; Studies of TNF
inhibitor pharmaceuticals in RA patients. Studies of NSAID
pharmaceuticals in RA patients.
Subinvestigator: Compliance study of osteoporosis
patients; NSAID treatment of OA. Studies of biologic
pharmaceuticals.
Robert L. McArthur, MD
Internal Medicine/Rheumatology. Principal Investigator:
Studies of IV biologics in SLE and RA, Studies of NSAID treatment
of OA.
Subinvestigator: TNF pharmaceutical in RA; pharmaceutical
treatment of osteoporosis; Compliance study of osteoporosis
patients; NSAID treatment of OA. Studies of biologic
pharmaceuticals for RA and SLE.
Thomas Janssen, MD
Orthopedic Surgery. Principal Investigator:Investigational
narcotic study for OA pain.
Subinvestigator: NSAID treatment of OA.
Brock E. Schnebel, MD
Orthopedic Surgery. Principal Investigator: Pharmaceutical
study of blood replacement after elective back surgery; study of
bone density in collegiate gymnasts.
Amy Shultz, MD
Internal Medicine/Rheumatology. Subinvestigator: Studies
of IV biologics in SLE.
Thomas K. Tkach, MD
Orthopedic Surgery. Principal Investigator: Component
study of tibial insert design in total knee arthroplasty; follow-up
study of total hip revision patients; studies of NSAID
pharmaceutical use immediately after total knee arthroplasty with
Apex hip stem.
Larry G. Willis, MD
Internal Medicine/Rheumatology. Principal Investigator:
Studies of IV biologics in SLE and RA. Compliance/long term side
effects study of osteoporosis patients; pharmaceutical study of
steroid - induced osteoporosis; pharmaceutical study of oral
osteoporosis drug.
Subinvestigator: Studies of IV biologics in SLE and RA.
Study of NSAID pharmaceuticals in OA patients; study of TNF
pharmaceuticals in RA; study of NSAID pharmaceuticals in RA;
pharmaceutical study of hypertension.
J. Calvin Johnson, M.D.
Principal Investigator: Therapeutic use of topical
hyaluronic acid for joint inflammatory conditions in the knee.
Sports medicine, knee and shoulder surgery fellowship. Specializing
in sports medicine, sports injuries, shoulder and knee arthroscopic
surgery.
Robert F. Hines, M.D.
Principal Investigator: Overtraining in athletes.
Specializing in sports medicine, sports injuries, shoulder and knee
arthroscopic surgery.
Jimmy H. Conway, M.D.
Specializing in shoulder, knee, sports medicine, complex sports
injuries and shoulder arthroscopic surgery.
Steven D. Coupens, M.D.
Sports medicine fellowship. Specializing in general orthopedics,
joint reconstruction, shoulder, knee, sports medicine and
foot/ankle.
William H. Herndon, M.D.
Pediatric orthopedics and spinal deformities fellowship.
Specializing in adolescent and pediatric orthopedics, sports
medicine and spine.
Helen Kelley, RN, Ph.D., CCRP
Doctorate in Epidemiology/Biostatistics Twenty years
experience designing, implementing, and analyzing studies in
general surgery, orthopedics, and internal medicine/rheumatology;
SoCRA certification 2007. Nine years nursing experience in
medical/surgical care of adults. Serves as subinvestigator on all
Research Department studies. Areas of particular interest include
biologic treatments of inflammatory arthritis, total knee
arthroplasty, medical writing, survey research, and incidence of
venous thromboembolism after orthopedic surgery.
Daniel L. Dodson, Ph.D., A.T.,C.
Doctorate in Health, Leisure, and Human Performance/Certified
Athletic Trainer Five years designing, implementing, and
analyzing studies in athletics and orthopedics; 18 years experience
as NATA certified athletic trainer. Areas of particular interest
include overtraining syndrome especially in rehabilitation,
hyaluronic acid in joint pain associated with OA.
Reda Mewhorter, MLT (ACSP), CCRP
American Society of Clinical Pathologists/Certified Medical
Laboratory Technician Seven years experience coordinating
clinical trials; SoCRA certification 2007. Twenty-five plus years
experience in medical laboratories, including the oversight of the
quality control laboratory for a large blood institute as well as
the coordination of both industry and government sponsored research
programs.
Lori A. Patton, MT, (ASCP), CCRP
American Society of Clinical Pathologists/Registered Medical
Technologist. Eight years experience coordinating clinical
trials; SoCRA certification 2007. Seventeen-plus years experience
in a variety of clinical laboratory areas including laboratory
information systems, quality control and routine blood testing.
Delana Rodgers, LPN
Licensed Practical NurseClinical trials study coordinator
since Fall 2007. Three and one half years working at Bone &
Joint Hospital, working in Rehabilitation unit as Certified Nursing
Assistant and Emergency Room as unit secretary.
The Oklahoma City metropolitan area is home to over one million
people; in addition, our clinic patients originate from parts of
Kansas, Texas, and Arkansas. We have a large population of elderly
patients, but also draw a number of younger patients with chronic
joint problems, connective tissue disease, trauma, and sports
injuries. Additionally, we treat a moderate number of patients who
are Native American and a small number of African Americans and
Asians.
